All the tumor-specific CD8+ T cells that we analyzed (n=6) proved to recognize mutant peptides, which is in line with a higher tumor mutational burden in this tumor than in those of patients UC2, UC3 and UC4 (Table 3), and an intact HLA class I expression in the tumor. Here, CD8A is linked to neoplasm.